- Home
- VATE vs BOLD Comparison
VATE vs BOLD Comparison
Compare VATE & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- BOLD
- Stock Information
- Founded
- VATE 1994
- BOLD 2018
- Country
- VATE United States
- BOLD United States
- Employees
- VATE 4024
- BOLD N/A
- Industry
- VATE Metal Fabrications
- BOLD
- Sector
- VATE Industrials
- BOLD
- Exchange
- VATE Nasdaq
- BOLD Nasdaq
- Market Cap
- VATE 82.6M
- BOLD 81.0M
- IPO Year
- VATE 1996
- BOLD 2024
- Fundamental
- Price
- VATE $6.10
- BOLD $2.95
- Analyst Decision
- VATE
- BOLD Strong Buy
- Analyst Count
- VATE 0
- BOLD 3
- Target Price
- VATE N/A
- BOLD $23.00
- AVG Volume (30 Days)
- VATE 50.3K
- BOLD 57.8K
- Earning Date
- VATE 11-06-2024
- BOLD 11-11-2024
- Dividend Yield
- VATE N/A
- BOLD N/A
- EPS Growth
- VATE N/A
- BOLD N/A
- EPS
- VATE N/A
- BOLD N/A
- Revenue
- VATE $1,364,600,000.00
- BOLD N/A
- Revenue This Year
- VATE N/A
- BOLD N/A
- Revenue Next Year
- VATE N/A
- BOLD N/A
- P/E Ratio
- VATE N/A
- BOLD N/A
- Revenue Growth
- VATE N/A
- BOLD N/A
- 52 Week Low
- VATE $3.25
- BOLD $2.82
- 52 Week High
- VATE $14.60
- BOLD $15.24
- Technical
- Relative Strength Index (RSI)
- VATE 71.67
- BOLD N/A
- Support Level
- VATE $6.18
- BOLD N/A
- Resistance Level
- VATE $6.49
- BOLD N/A
- Average True Range (ATR)
- VATE 0.43
- BOLD 0.00
- MACD
- VATE 0.05
- BOLD 0.00
- Stochastic Oscillator
- VATE 86.72
- BOLD 0.00
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.